Company ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 11/12/2025 GMT			5-day change	1st Jan Change
189.93 ^USD	+2.19%		+2.24%	-9.43%

12-09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
12-02	Icon survey reveals increasing clinical trial startup delays	RE

Business description: ICON Public Limited Company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Number of employees: 39,800

Sales by Activity: ICON Public Limited Company

Fiscal Period: December	2020	2021	2022	2023	2024
Medical Labs & Research	2.8B	5.48B	7.74B	8.12B	8.28B

See all business segments

Geographical breakdown of sales: ICON Public Limited Company

Fiscal Period: December	2020	2021	2022	2023	2024
United States (U.S.)	926M	2.58B	3.57B	3.28B	2.99B
Ireland	1.18B	1.37B	1.98B	2.38B	2.79B
Rest of Europe	417M	1.18B	1.62B	1.57B	1.56B
Rest of world	274M	358M	564M	884M	943M

See all geographic segments

Executive Committee: ICON Public Limited Company

Manager	Title	Age	Since
Nigel Bernard John Clerkin DFI	Director of Finance/CFO	52	30/09/2024
Tom O'Leary CTO	Chief Tech/Sci/R&D Officer	-	-
Diarmaid Cunningham ADM	Chief Administrative Officer	50	30/06/2016
Simon Holmes CIO	Chief Investment Officer	-	-
Kate Haven IRC	Investor Relations Contact	-	-

See ICON PUBLIC LIMITED COMPANY governance

Composition of the Board of Directors: ICON Public Limited Company

Director	Title	Age	Since
John Climax CHM	Chairman	72	31/10/2002
Ciaran Murray CHM	Chairman	62	28/02/2017
Stephen Cutler BRD	Director/Board Member	64	24/11/2015
Eugene McCague BRD	Director/Board Member	66	03/10/2017
Rónán Murphy BRD	Director/Board Member	67	17/10/2016
Julie O'Neill BRD	Director/Board Member	59	22/07/2019
Linda Grais BRD	Director/Board Member	67	30/06/2021
Anne Michelle Whitaker BRD	Director/Board Member	57	22/07/2024

Composition of the Board of Directors

Shareholders: ICON Public Limited Company

Name	Equities	%	Valuation
Artisan Partners Holdings LP 9.261 %	7,071,360	9.261 %	1 308 M $
Wellington Trust Co., NA 6.073 %	4,637,137	6.073 %	858 M $
Orbis Investment Management Ltd. 5.42 %	4,138,818	5.42 %	766 M $
MFS Investment Management Canada Ltd. 4.588 %	3,503,553	4.588 %	648 M $
Invesco Advisers, Inc. 4.489 %	3,427,630	4.489 %	634 M $

List of ICON PUBLIC LIMITED COMPANY shareholders

Company details: ICON Public Limited Company

ICON plc

South County Business Park

18, Dublin

+353 1 291 2000

http://www.iconplc.com

address ICON Public Limited Company(ICLR)

Group companies: ICON Public Limited Company

Name	Category and Sector
ICON Clinical Research India Pvt Ltd. ICON Clinical Research India Pvt Ltd. Provides clinical research and development services
ICON Clinical Research Ltd. ICON Clinical Research Ltd. Provides consulting, outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, government and public health organisations
Icon Investments (UK) Ltd.
DOCS Resourcing Ltd. DOCS Resourcing Ltd. Provides health care services
ICON Global Treasury Unlimited Co. ICON Global Treasury Unlimited Co. Provides financial services

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ICON PUBLIC LIMITED COMPANY	+2.19%	+2.24%	-10.49%	-2.48%	14.5B
LONZA GROUP AG	-1.30%	-4.68%	-5.55%	+11.74%	46.35B
IQVIA HOLDINGS INC.	+1.37%	+0.47%	+12.39%	+8.37%	38.48B
BEONE MEDICINES AG	-0.57%	-3.19%	+74.01%	+62.86%	35.5B
CELLTRION, INC.	+0.54%	+2.25%	+10.68%	+17.47%	27.77B
MEDPACE HOLDINGS, INC.	+0.96%	+3.92%	+65.78%	+175.14%	15.95B
REVOLUTION MEDICINES, INC.	+0.81%	+0.04%	+69.09%	+230.15%	15.18B
TEMPUS AI, INC.	-1.61%	-3.24%	+71.01%	-	13.14B
IONIS PHARMACEUTICALS, INC.	+0.65%	-3.26%	+108.32%	+111.04%	12.82B
ASCENDIS PHARMA A/S	+4.43%	+0.76%	+56.51%	+79.52%	12.84B
Average	+0.88%	-0.48%	+45.18%	+77.09%	23.25B
Weighted average by Cap.	+0.45%	-0.98%	+34.99%	+55.96%